Phase I study for the efficacy and the safety of the perioperative urinastatin therapy in chest surgical patients with interstitial pneumonia.
Phase 1
Recruiting
- Conditions
- interstitial pneumonia, lung cancer, metastatic lung tumor, pneumothorax
- Registration Number
- JPRN-UMIN000003295
- Lead Sponsor
- Tokyo Women's Medical University of Medicine, Department of Surgery I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.Having the history of allergic reaction against ulinastatin. 2.Asbestosis. 3.Chronic hypersensitivity pneumonitis. 4.Sarcoidosis. 5.Pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Judging whether a side effect of the ulinastatin appeared. Evaluating the kind of the side effect, frequency, grade of the ulinastatin.
- Secondary Outcome Measures
Name Time Method Judging whether acute exacerbation of the postoperative interstitial pneumonia appeared.